Frataxin Deacetylation in Macrophages: Avoiding SIRTain Myocyte Death
Circulation Research · 2023
DOI: 10.1161/circresaha.123.323503 ↗Kurz gefasst
Editorial in der Zeitschrift Circulation Research, 2023. Verfasst von Ronald J Vagnozzi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology (R.J.V., E.L.R.), University of Colorado Anschutz Medical Campus, Aurora. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Sirtuin 3. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology (R.J.V., E.L.R.), University of Colorado Anschutz Medical Campus, Aurora.
- Consortium for Fibrosis Research and Translation (R.J.V., E.L.R.), University of Colorado Anschutz Medical Campus, Aurora.
- Gates Institute (R.J.V.), University of Colorado Anschutz Medical Campus, Aurora.
ORCID-Profile: Ronald J Vagnozzi, Emma L Robinson
Förderung
- NHLBI NIH HHS
Zitieren
APA
Vagnozzi, R. J., & Robinson, E. L. (2023). Frataxin Deacetylation in Macrophages: Avoiding SIRTain Myocyte Death. Circulation Research. https://doi.org/10.1161/circresaha.123.323503
Vancouver
Vagnozzi RJ, Robinson EL. Frataxin Deacetylation in Macrophages: Avoiding SIRTain Myocyte Death. Circulation Research. 2023. doi:10.1161/circresaha.123.323503
BibTeX
@article{Vagnozzi2023,
author = {Vagnozzi, Ronald J and Robinson, Emma L},
title = {Frataxin Deacetylation in Macrophages: Avoiding SIRTain Myocyte Death},
journal = {Circulation Research},
year = {2023},
doi = {10.1161/circresaha.123.323503}
}
EUVIMED